These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24375774)

  • 1. One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): toward an upfront simplified "all-in-one" imaging approach?
    Pasoglou V; Larbi A; Collette L; Annet L; Jamar F; Machiels JP; Michoux N; Vande Berg BC; Tombal B; Lecouvet FE
    Prostate; 2014 May; 74(5):469-77. PubMed ID: 24375774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
    Lecouvet FE; El Mouedden J; Collette L; Coche E; Danse E; Jamar F; Machiels JP; Vande Berg B; Omoumi P; Tombal B
    Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Metser U; Berlin A; Halankar J; Murphy G; Jhaveri KS; Ghai S; Tau N
    AJR Am J Roentgenol; 2018 Mar; 210(3):635-640. PubMed ID: 29323548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.
    Lecouvet FE; Geukens D; Stainier A; Jamar F; Jamart J; d'Othée BJ; Therasse P; Vande Berg B; Tombal B
    J Clin Oncol; 2007 Aug; 25(22):3281-7. PubMed ID: 17664475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do patients who undergo multiparametric MRI for prostate cancer benefit from additional staging imaging? Results from a statewide collaborative.
    Eyrich NW; Tosoian JJ; Drobish J; Montie JE; Qi J; Kim T; Noyes SL; Moriarity AK; Lane BR;
    Urol Oncol; 2020 Jul; 38(7):636.e13-636.e19. PubMed ID: 32067844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma.
    Müller-Horvat C; Radny P; Eigentler TK; Schäfer J; Pfannenberg C; Horger M; Khorchidi S; Nägele T; Garbe C; Claussen CD; Schlemmer HP
    Eur J Cancer; 2006 Feb; 42(3):342-50. PubMed ID: 16364631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.
    Pfannenberg C; Aschoff P; Schanz S; Eschmann SM; Plathow C; Eigentler TK; Garbe C; Brechtel K; Vonthein R; Bares R; Claussen CD; Schlemmer HP
    Eur J Cancer; 2007 Feb; 43(3):557-64. PubMed ID: 17224266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature.
    Giannarini G; Petralia G; Thoeny HC
    Eur Urol; 2012 Feb; 61(2):326-40. PubMed ID: 22000497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body magnetic resonance imaging for staging patients with high-risk prostate cancer.
    Fang AM; Chapin BF; Shi CW; Sun J; Qayyum A; Kundra V; Corn PG; Kuban DA; Ravizzini GC; Surasi DSS; Ma J; Bathala TK
    Prostate Cancer Prostatic Dis; 2024 Sep; ():. PubMed ID: 39289537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
    Budiharto T; Joniau S; Lerut E; Van den Bergh L; Mottaghy F; Deroose CM; Oyen R; Ameye F; Bogaerts K; Haustermans K; Van Poppel H
    Eur Urol; 2011 Jul; 60(1):125-30. PubMed ID: 21292388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric MRI - local staging of prostate cancer and beyond.
    Caglic I; Kovac V; Barrett T
    Radiol Oncol; 2019 May; 53(2):159-170. PubMed ID: 31103999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
    Harisinghani MG; Barentsz J; Hahn PF; Deserno WM; Tabatabaei S; van de Kaa CH; de la Rosette J; Weissleder R
    N Engl J Med; 2003 Jun; 348(25):2491-9. PubMed ID: 12815134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of MRI in the management of a prostate cancer patient with bone and lymph nodes metastases. A case report.
    Belmonte M; Saia G; Zugni F; Alessi S; Colombo A; Summers PE; Luzzago S; Marvaso G; Musi G; De Cobelli O; Jereczek-Fossa BA; Petralia G
    Acta Biomed; 2021 Sep; 92(4):e2021214. PubMed ID: 34487080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate.
    Kuru TH; Roethke MC; Rieker P; Roth W; Fenchel M; Hohenfellner M; Schlemmer HP; Hadaschik BA
    BJU Int; 2013 Dec; 112(8):1080-7. PubMed ID: 23937255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
    Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
    J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body magnetic resonance imaging in myxoid liposarcoma: A useful adjunct for the detection of extra-pulmonary metastatic disease.
    Stevenson JD; Watson JJ; Cool P; Cribb GL; Jenkins JP; Leahy M; Gregory JJ
    Eur J Surg Oncol; 2016 Apr; 42(4):574-80. PubMed ID: 26831007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy.
    Robertson NL; Sala E; Benz M; Landa J; Scardino P; Scher HI; Hricak H; Vargas HA
    J Urol; 2017 Jul; 198(1):65-70. PubMed ID: 28216327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body MRI of neuroblastoma.
    Goo HW
    Eur J Radiol; 2010 Sep; 75(3):306-14. PubMed ID: 19781884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.
    Wang L; Hricak H; Kattan MW; Schwartz LH; Eberhardt SC; Chen HN; Scardino PT
    AJR Am J Roentgenol; 2006 Mar; 186(3):743-8. PubMed ID: 16498101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.